Takeda Gets Key U.S. Regulatory Approval To Buy Shire - FbiCables Network | The News that Shapes World Opinion

Top Stories

Tuesday, July 10, 2018

Takeda Gets Key U.S. Regulatory Approval To Buy Shire


Shire branding is seen outside their offices in Dublin
Shire branding is seen outside their offices in Dublin, Ireland, April 25, 2018. REUTERS/Clodagh Kilcoyne
July 10, 2018
TOKYO (Reuters) – Japan’s Takeda Pharmaceutical Co Ltd said on Tuesday it received a key U.S. regulatory approval for the $62 billion acquisition of London-listed Shire Plc.
Takeda has received unconditional clearance from the United States Federal Trade Commission for the Shire deal, the drugmaker said.
The Shire deal would turn Takeda into one of the world’s largest drugmakers.
However, the remaining hurdles for the Tokyo-listed company include getting a regulatory nod from the European Union and China and approval from shareholders of both drugmakers.
Chief Executive Christophe Weber has been working to persuade investors about the deal, which has weighed heavily on Takeda’s stock price.
Takeda shares closed flat on Tuesday, while the statement was released after trading hours.
It expects the deal to close in the first half on 2019, Takeda said.

No comments:

Post a Comment